BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Peter Lawson does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 MGNXMacroGenics Inc | Buy | $3.00 | May 2025 | +156.9% | Hit |
 FATEFate Therapeutics Inc | Buy | $2.00 | May 2025 | +74.9% | Hit |
 KPTIKaryopharm Therapeutics Inc | Buy | $10.00 | May 2025 | +66.5% | Hit |
 IOVAIovance Biotherapeutics Inc | Buy | $4.00 | May 2025 | +86.3% | Hit |
 XNCRXencor Inc | Sell | $6.00 | May 2025 | −44.3% | Miss |
 KURAKura Oncology Inc | Buy | $11.00 | May 2025 | +31.0% | Hit |
 ARVNArvinas Inc | Buy | $16.00 | May 2025 | +34.6% | Miss |
 BCYCBicycle Therapeutics Ltd | Buy | $15.00 | May 2025 | −55.0% | Miss |
 RCUSArcus Biosciences Inc | Buy | $14.00 | Apr 2025 | +190.5% | Hit |
| IOVAIovance Biotherapeutics Inc | Buy | $5.00 | Apr 2025 | +2.7% | Hit |
 GERNGeron Corporation | Buy | $4.00 | Feb 2025 | −14.0% | Miss |
| RCUSArcus Biosciences Inc | Buy | $29.00 | Oct 2024 | +11.5% | Miss |
| MGNXMacroGenics Inc | Buy | $8.00 | Jul 2024 | −48.8% | Miss |
| MGNXMacroGenics Inc | Buy | $9.00 | Jul 2024 | −60.9% | Miss |
| MGNXMacroGenics Inc | Buy | $14.00 | May 2024 | −60.0% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.